NCT04985383View on ClinicalTrials.gov

Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 11, 2021

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
End-Stage Renal Disease
Interventions
DEVICE

AKST1210 S-15 at 250 mL/min

Procedure: Hemodialysis, AKST1210 column size 150mL and blood-flow rate at 250mL/min

DEVICE

AKST1210 S-15 at 450 mL/min

Procedure: Hemodialysis, AKST1210 column size 150mL and blood-flow rate at 450mL/min

DEVICE

AKST1210 S-25 at 250 mL/min

Procedure: Hemodialysis, AKST1210 column size 250mL and blood-flow rate at 250mL/min

DEVICE

AKST1210 S-25 at 450 mL/min

Procedure: Hemodialysis, AKST1210 column size 250mL and blood-flow rate at 450mL/min

DEVICE

AKST1210 S-35 at 250 mL/min

Procedure: Hemodialysis, AKST1210 column size 350mL and blood-flow rate at 250mL/min

DEVICE

AKST1210 S-35 at 450 mL/min

Procedure: Hemodialysis, AKST1210 column size 350mL and blood-flow rate at 450mL/min

Trial Locations (4)

78251

US Renal Care - Westover Hills Dialysis, San Antonio

87301

US Renal Care, Gallup

91324

Valley Renal Medical Group Research, Northridge

91344

Renal Consultant Medical Group, Granada Hills

Sponsors

Lead Sponsor

Alkahest, Inc.
All Listed Sponsors
lead

Alkahest, Inc.

INDUSTRY